Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Intercept Pharmaceuticals
(NQ:
ICPT
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Intercept Pharmaceuticals
< Previous
1
2
3
4
5
6
7
Next >
Intercept Shares Fall After Interim Analysis On Late-Stage NASH Study
July 07, 2022
Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) announced positive topline results from a new interim analysis of its ongoing pivotal Phase 3 REGENERATE trial of OCA in patients with liver fibrosis due...
Via
Benzinga
R&D Efforts for Central Nervous System (CNS) Therapeutics Have Resulted in Hopeful Novel Drug-Delivery Solutions
June 29, 2022
Palm Beach, FL – June 29 2022 – FinancialNewsMedia.com News Commentary – In the central nervous system (CNS) therapeutics market, large and small pharmaceutical companies are highly investing in the...
Via
FinancialNewsMedia
Regulatory Update On Intercept Pharma's Obeticholic Acid For NASH Delayed Again
June 06, 2022
Via
Benzinga
Analysts Expect Clarity Imminent On Intercept's NASH Story
May 09, 2022
Via
Benzinga
Analyst Ratings for Intercept Pharmaceuticals
May 09, 2022
Intercept Pharmaceuticals (NASDAQ:ICPT) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Why Intercept Shares Are Rising Today
May 05, 2022
Intercept Pharmaceuticals Inc (NASDAQ: ICPT) has
Via
Benzinga
Intercept Pharma Scores $450 Million Deal For Its Flagship Liver Drug
May 05, 2022
A U.K.-based pharmaceutical company will sell Ocaliva outside the U.S.
Via
Investor's Business Daily
Jim Cramer Prefers This Oil Stock Over Occidental Petroleum
June 06, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) is a total spec.
Via
Benzinga
Intercept Pharmaceuticals's Return On Capital Employed Overview
June 01, 2022
According to data from Benzinga Pro, during Q1, Intercept Pharmaceuticals's (NASDAQ:ICPT) reported sales totaled $88.58 million. Despite a 52.36% increase in earnings, the company posted a loss of...
Via
Benzinga
Global Psychedelics Market Is Expected To Reach $8 Billion By 2029
May 24, 2022
Palm Beach, FL – May 24, 2022 – FinancialNewsMedia.com News Commentary – The Global psychedelic drugs market has been steadily rising for the past few years and is projected to continue at a faster...
Via
FinancialNewsMedia
First Patient Dosed in Phase 2 Study of Intercept's OCA and Bezafibrate Combination for Primary Biliary Cholangitis
May 11, 2022
Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) dosed first patient in a Phase 2 study evaluating a fixed-dose combination of obeticholic acid (OCA) and bezafibrate (BZF) for the treatment of patients...
Via
Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
May 06, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Intercept Pharmaceuticals: Q1 Earnings Insights
May 06, 2022
Intercept Pharmaceuticals (NASDAQ:ICPT) reported its Q1 earnings results on Friday, May 6, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Outlook For Intercept Pharmaceuticals
May 05, 2022
Intercept Pharmaceuticals (NASDAQ:ICPT) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Drops 650 Points; Silicon Motion Shares Spike Higher
May 05, 2022
U.S. stocks remained lower toward the end of trading, with the Nasdaq Composite dropping more than 650 points on Thursday.
Via
Benzinga
83 Biggest Movers From Yesterday
May 06, 2022
Gainers Hudson Technologies, Inc. (NASDAQ: HDSN) shares jumped 26.9% to close at $9.06 on Thursday after the company reported better-than-expected Q1 EPS and sales results.
Via
Benzinga
Earnings Scheduled For May 6, 2022
May 06, 2022
Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEP) is expected to report quarterly loss at $0.02 per share on revenue of $1.27 billion.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
May 05, 2022
Via
Benzinga
Dow Sheds Nearly 1,000 Points as Selloff Deepens
May 05, 2022
Stocks are sharply lower at midday, in what is shaping up to be another volatile day on Wall Street.
Via
Talk Markets
Mid-Day Market Update: U.S. Stocks Extend Losses; Dow Dips Over 1,100 Points
May 05, 2022
U.S. stocks extended losses midway through trading, with the Dow Jones dipping more than 1,100 points on Thursday.
Via
Benzinga
Why Is Intercept Pharmaceuticals (ICPT) Stock Up Today?
May 05, 2022
Intercept Pharmaceuticals (ICPT) stock is soaring higher on Thursday after the biopharmaceutical company revealed a deal with Advanz Pharma.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 05, 2022
Via
Benzinga
57 Stocks Moving In Thursday's Mid-Day Session
May 05, 2022
Gainers
Via
Benzinga
Intercept Pharmaceuticals Q1 2022 Earnings Conference Call On May 6, 2022 At 08:30 AM ET
May 03, 2022
Intercept Pharmaceuticals (NASDAQ:ICPT) will host a conference call at 08:30 AM ET on May 6, 2022, to discuss Q1 2022 earnings results.
Via
Benzinga
7 Potential Biotech Stocks Buyout Targets in 2022
April 21, 2022
Drug development is a cumbersome process and M&A is a win-win proposition for both the acquirer and the target company.
Via
InvestorPlace
Short-Squeeze Stocks: Top 10 Stocks With High Short Interest Today
March 15, 2022
Short-squeeze stocks continue to be a hot topic with retail traders and we're going over the top ones to keep an eye on for Tuesday!
Via
InvestorPlace
Looking Into Intercept Pharmaceuticals's Return On Capital Employed
March 08, 2022
Intercept Pharmaceuticals (NASDAQ:ICPT) brought in sales totaling $92.40 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 898.9%,...
Via
Benzinga
Analyst Ratings For Intercept Pharmaceuticals
March 03, 2022
Analysts have provided the following ratings for Intercept Pharmaceuticals (NASDAQ:ICPT) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 02, 2022
Gainers IsoPlexis (NASDAQ:ISO) shares moved upwards by 22.8% to $5.5 during Wednesday's pre-market session. The company's market cap stands at $214.2 million. The...
Via
Benzinga
Intercept Pharmaceuticals: Q4 Earnings Insights
March 02, 2022
Intercept Pharmaceuticals (NASDAQ:ICPT) reported its Q4 earnings results on Wednesday, March 2, 2022 at 07:00 AM. Here's what investors need to know about the...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.